CYP3A5 Genotype Impacts Maraviroc Concentrations in Healthy Volunteers

Lignende værker

• Response to “Clinical Relevance of CYP3A5 Genotype on Maraviroc Exposures”
  af: Lu, Yanhui, et al.
  Udgivet: (2015)
• Cytochrome P450 3A5 Plays a Prominent Role in the Oxidative Metabolism of the Anti-Human Immunodeficiency Virus Drug Maraviroc
  af: Lu, Yanhui, et al.
  Udgivet: (2012)
• Effects of CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers
  af: Abel, Samantha, et al.
  Udgivet: (2008)
• No Clinical Impact of CYP3A5 Gene Polymorphisms on the Pharmacokinetics and/or Efficacy of Maraviroc in Healthy Volunteers and HIV‐1–Infected Subjects
  af: Vourvahis, Manoli, et al.
  Udgivet: (2018)
• Clinical Relevance of CYP3A5 Genotype on Maraviroc Exposures
  af: Vourvahis, Manoli, et al.
  Udgivet: (2015)